Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, May 2003, p. 383-387, Vol. 10, No. 3
1071-412X/03/$08.00+0 DOI: 10.1128/CDLI.10.3.383-387.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Section of Periodontology, Department of Oral Rehabilitation, Faculty of Dental Science, Kyushu University,1 Section of General Dentistry, Department of General Dentistry, Fukuoka Dental College,2 Department of Medicine, Fukuoka Prison, Fukuoka, Japan3
Received 7 October 2002/ Returned for modification 8 February 2003/ Accepted 22 February 2003
|
|
|---|
|
|
|---|
Because of the fastidious nature and difficulty in culture of this bacterium, pathogenicity of B. forsythus is not completely known. Only a few virulent factors have been identified, and these include trypsin-like protease (28), sialidase (11), apoptosis-inducing activity (1), prtH protease (22), and a cell surface-associated BspA protein (24). B. forsythus is also known to have a unique surface structure. As first reported by Tanner et al. (28), B. forsythus has an S-layer outside the outer membrane. The functions and pathogenicity of S-layers are not fully understood, but they are known to have crystalline protein or glycoprotein structures (25) and are considered to be related to molecular sieving, adhesion, and phage receptors (2). Virulence of S-layers is reported for some bacteria. S-layer of Aeromonas salmonicida is related to furnculosis in fish (12), and S-layer of Campylobacter fetus is considered to have an antiphagocytic function (31). Among periodontopathic bacteria, Campylobacter rectus (15) is also known to have an S-layer. The S-layer of C. rectus is considered to induce proinflammatory cytokines in patients with periodontitis (30). The functions of an S-layer of B. forsythus are as yet unknown, but Kerosuo suggests that S-layers may contribute to the rigidity of the cell wall (13). Recently, Higuchi et al. reported that 270- and 230-kDa proteins in the envelope fraction of B. forsythus are constituents of the S-layer of this bacterium (10).
On the other hand, patients with periodontitis are known to have high antibody titers against periodontopathic bacteria (6, 17). The humoral immune response has been extensively studied with P. gingivalis. Patients with severe periodontitis are known to have higher immunoglobulin G (IgG) titers against lipopolysaccharide (LPS) (23), fimbriae (20, 35), and gingipains (19), which are major pathogenic factors of this bacterium. In this way, higher antibody titers are in part correlated with the pathogenicity of bacteria. Humoral immune response against B. forsythus is not so extensively studied as that of P. gingivalis. Califano et al. could not detect higher antibody titers against a crude extract of B. forsythus in patients with periodontitis (3). On the other hand, Persson et al. (21) reported higher antibody titers against B. forsythus for patients with periodontitis compared to those of patients with gingivitis. Haffajee et al. grouped periodontitis subjects according to their elevated serum antibody levels to specific subgingival species (9). However, there is no report as of yet which has examined the immune reactions against purified antigens of B. forsythus in patients with periodontitis. In this study, we confirmed that S-layer-like proteins are specific antigens of B. forsythus and that they were found to be recognized by sera from patients with early-onset periodontitis (EOP) and adult periodontitis (AP).
|
|
|---|
Bacterial strains and growth conditions.
B. forsythus ATCC 43037 was maintained on CDC-anaerobic blood agar (BBL Microbiology Systems, Cockeysville, Md.) under anaerobic conditions (85% N2, 10% H2, 5% CO2). B. forsythus was grown in large scale in brain heart infusion broth (Difco Laboratories, Detroit, Mich.) containing 0.5% yeast extract, 5 µg of hemin per ml, 0.5 µg of menadione per ml, 0.001% N-acetylmuramic acid (Sigma Chemical Co., St. Louis, Mo.), and 5% fetal bovine serum (Gibco-BRL, Grand Island, N.Y.). Other bacteria, including P. gingivalis ATCC 33277, Bacteroides fragilis ATCC 25285, Fusobacterium nucleatum ATCC 25586, and Prevotella intermedia ATCC 25611, were grown in brain heart infusion broth containing 0.5% yeast extract, 5 µg of hemin per ml, and 0.5 µg of menadione per ml under anaerobic conditions (33). Escherichia coli DH5
was grown in Luria-Bertani broth (Gibco-BRL).
SDS-PAGE and Western immunoblot. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was performed with a 1-mm-thick 9% running gel according to the method described by Laemmli (14). For Western immunoblot analysis, proteins separated by SDS-PAGE were transferred to nitrocellulose membranes in 25 mM Tris-glycine buffer. The unoccupied sites on the membranes were blocked with phosphate-buffered saline (PBS) containing 5% dry skim milk powder (Difco). The membrane was then treated with the sera from HC and patients with EOP or AP (1:1,000). Preabsorption of sera was performed according to the method of Nardin et al. (18). Sera were incubated with formalin-killed bacterial cell mix which contained P. gingivalis, P. intermedia, B. fragilis, F. nucleatum, and E. coli at 4°C overnight, and bound antibodies on bacterial cells were removed by centrifugation. The membranes were washed and incubated with goat anti-human IgG conjugated with alkaline phosphatase (1:2,000; Bio-Rad). The membranes were washed, and the bound antibodies were visualized by using 5-bromo-4-chloro-3-indolyl-1-phosphate and nitroblue tetrazolium (Bio-Rad).
Purification of S-layer from B. forsythus.
S-layer-like proteins were purified from sonicated extract of B. forsythus ATCC 43037 according to the methods of Higuchi et al. (10). In brief, the washed cells were sonicated on ice in the presence of protease inhibitors (0.25 mM N-
-p-tosyl-L-lysine chloromethyl ketone, 0.2 mM phenylmethylsulfonyl fluoride, and 0.1 mM leupeptin; Sigma). The cell extracts were obtained by removing the unbroken cells by centrifugation, and the envelope fraction was separated from the soluble fraction by ultracentrifugation at 143,000 x g for 60 min. The envelope fractions were subjected to SDS-PAGE, and the 270- and 230-kDa bands were excised and collected. Each protein was eluted from the gel slices by using an electroelutor (Model 422; Bio-Rad).
ELISA. Enzyme-linked immunosorbent assay (ELISA) was performed according to the modified methods of O'Brien-Simpson et al. (19). Ninety-six-well microtiter plates were coated with the crude or purified antigens of B. forsythus at 4°C overnight. After removing the unbound antigens, the uncoated wells were blocked with PBS containing 3% bovine serum albumin (blocking buffer) at room temperature for 1 h. After being washed, serially diluted subject sera in the blocking buffer were added and incubated at 37°C for 3 h. After being washed, goat anti-human IgG conjugated with alkaline-phosphatase (1:1,000 dilution; Bio-Rad) was added and incubated for 1.5 h at 37°C. After being washed, p-nitrophenylphosphate (Bio-Rad) was added to the wells and the optical density (OD) at 405 nm of the developed color was measured by using a microplate reader. The assays were performed with triplicate wells for each individual serum, and the median data were used for analysis.
|
|
|---|
![]() View larger version (82K): [in a new window] |
FIG. 1. SDS-PAGE of sonicated extracts of B. forsythus and other gram-negative bacteria on a 9% gel. Lanes: 1, molecular size standard; 2, B. forsythus ATCC 43037; 3, B. fragilis ATCC 25285; 4, F. nucleatum ATCC 25586; 5, P. intermedia ATCC 25611; 6, P. gingivalis ATCC 33277; 7, E. coli DH5 . B. forsythus exhibited the characteristic two high-molecular-size bands of 270 and 230 kDa.
|
![]() View larger version (60K): [in a new window] |
FIG. 2. Western immunoblot analysis. Sonicated extract of B. forsythus was separated on 9% gels and was transferred to nitrocellulose membranes. Membranes were excised, and each strip was probed with preabsorbed sera from human subjects (1:1,000) followed by goat anti-human IgG conjugated with alkaline phosphatase (1:2,000). Lanes: 1, prestained molecular size marker; 2 to 7, sera from patients with EOP; 8 to 16, sera from patients with AP; 17 to 19, sera from HC. All sera from patients and two sera from HC recognized 270- and 230-kDa proteins (arrows).
|
![]() View larger version (48K): [in a new window] |
FIG. 3. (A) SDS-PAGE of S-layer-like antigens of B. forsythus on 9% gels. Lanes: 1, molecular size standard; 2, sonicated extracts of B. forsythus; 3, purified 270-kDa protein; 4, purified 230-kDa protein. (B) Western immunoblot analysis of S-layer-like antigens of B. forsythus. Purified antigens were loaded on 9% gels and were transferred to nitrocellulose membranes. Membranes were probed with nonabsorbed serum from a patient with EOP (1:2,000) followed by goat anti-human IgG conjugated with alkaline phosphatase (1:2,000). Lanes: 1, prestained molecular size marker; 2, purified 270-kDa protein; 3, purified 230-kDa protein.
|
|
View larger version (8K): [in a new window] |
FIG. 4. Western immunoblot analysis with the purified 270-kDa antigen. The purified 270-kDa antigen was transferred to nitrocellulose membrane after SDS-PAGE. Membranes were excised, and each strip was probed with nonabsorbed sera from human subjects (1:2,000) followed by goat anti-human IgG conjugated with alkaline phosphatase (1:2,000). Lanes: 1 to 3, sera from patients with EOP; 4 to 9, sera from patients with AP; 10 to 12, sera from HC.
|
![]() View larger version (18K): [in a new window] |
FIG. 5. (A) IgG responses against sonicated extract from B. forsythus. Microtiter wells coated with sonicated extract were blocked with PBS containing bovine serum albumin and then were incubated with 1:500-diluted nonabsorbed sera from human subjects. The microtiter wells were then incubated with goat anti-human IgG conjugated with alkaline phosphatase (1:1,000) and color was developed with p-nitrophenylphosphate. (B) IgG responses against purified 270-kDa S-layer-like antigen. The procedures were same as those described for panel A. EOP, sera from patients with EOP (n = 9); AP, sera from patients with AP (n = 27); HC, sera from HC (n = 11). An asterisk means significantly different from HC (P < 0.005).
|
|
|
|---|
Higuchi et al. (10) reported that S-layer-like proteins of B. forsythus had a strong antigenicity in rabbits, and our results supported the finding of antigenicity in human subjects as well. Two-hundred seventy- and 230-kDa proteins showed similar antigenicity, and this was also confirmed with the purified antigens (Fig. 3B). Higuchi et al. also reported that these two proteins are considered to be encoded by the same gene, and the difference in size may come from the difference in processing (10).
The IgG responses against S-layer-like antigens measured by ELISA were higher for patients with EOP and AP than for HC donors, although we could not obtain such difference when we used the crude extract of B. forsythus as an antigen. Our results indicated that S-layer-like antigens of B. forsythus were recognized by sera of patients with periodontitis and that the difference of antibody responses between patients and healthy donors were statistically significant, but the overall responses were very low compared to those against other bacterial antigens, such as P. gingivalis (data not shown). Due to the low IgG responses against B. forsythus, we did not show the exact titers of the antibodies. We need to compare the titers among subject groups by more sensitive methods in the future. Califano et al. also reported the lower response against the sonicated extract of B. forsythus compared to that of P. gingivalis in patients with periodontitis (3). It may be because of the low penetrating activity of B. forsythus into periodontal tissues or the low antigenicity of this organism. They also reported that there was not a significant difference between patients with periodontitis and healthy donors. Our data, which were performed with the sonicated extract antigen, supported their results. One of the reasons that there was not a significant difference among these patient groups may be the presence of common antigen among oral and nonoral bacteria. Healthy donors may have antibodies against such antigens, and we may have failed to count the specific immune response to B. forsythus. Further studies will be necessary to identify the true reason by using greater numbers of patients.
In any event, the S-layer-like proteins were specifically recognized by patients with periodontitis, so the S-layer of B. forsythus may have potential as a pathogenic factor as reported for S-layers of other bacteria (12, 30, 31). We cannot exclude the possibility that the S-layer-like proteins used in this experiment were contaminated with LPS, but we did not detect the characteristic ladder pattern of LPS by Western immunoblot, so the content of LPS is negligible in this experiment. We are now trying to isolate ultrapure S-layer-like antigens devoid of LPS for further bioassay.
Periodontitis is now considered to be the typical biofilm infection, and a mixed infection of several periodontopathic bacteria is the cause of this chronic disease (26). Takemoto et al. (27) reported that coinfection of B. forsythus and P. gingivalis induced larger abscess formation in rabbits compared to that of monoinfection with each bacterium. This synergism was previously confirmed by using a mouse model, and it was found that this synergism is in part related to the gingipains of P. gingivalis (34), but the virulence factors in B. forsythus could not be found in that experiment. Our results in this study revealed that S-layer of B. forsythus is a specific antigen of this bacterium. S-layer of B. forsythus may play an important role in biofilm formation in periodontal tissues. We are now constructing the isogenic mutant strain of B. forsythus devoid of S-layer-like antigens. Thus, we will be better able to study the function and virulence of S-layer of B. forsythus, and we will be able to access the mechanism of synergism between B. forsythus and P. gingivalis.
This work was supported in part by Grants-in-Aid from Scientific Research 13672189 from the Ministry of Education, Sports, and Culture of Japan.
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»